ArticleCancer management and research2020

CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1.

Yunfei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.